Related references
Note: Only part of the references are listed.Functional Comparison of Engineered T Cells Carrying a Native TCR versus TCR-like Antibody-Based Chimeric Antigen Receptors Indicates Affinity/Avidity Thresholds
Ravit Oren et al.
JOURNAL OF IMMUNOLOGY (2014)
T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia
Armen Mardiros et al.
BLOOD (2013)
Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody
Tao Dao et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Neuroblastoma: developmental biology, cancer genomics and immunotherapy
Nai-Kong V. Cheung et al.
NATURE REVIEWS CANCER (2013)
Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1+ leukemias
Ekaterina Doubrovina et al.
BLOOD (2012)
Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor
D. V. Tassev et al.
CANCER GENE THERAPY (2012)
T-cell-receptor-like antibodies - generation, function and applications
Rony Dahan et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2012)
NK cells engineered to express a GD2-specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin
Ruth Esser et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Human Monoclonal Antibodies Targeting Nonoverlapping Epitopes on Insulin-like Growth Factor II as a Novel Type of Candidate Cancer Therapeutics
Weizao Chen et al.
MOLECULAR CANCER THERAPEUTICS (2012)
CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foe
David E. Gilham et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo
Nai-Kong V. Cheung et al.
ONCOIMMUNOLOGY (2012)
Characterization of chronic myeloid leukemia stem cells
Jonathan M. Gerber et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
An anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells
Anna Sergeeva et al.
BLOOD (2011)
Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation
Holbrook E. Kohrt et al.
BLOOD (2011)
Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy
Carlos A. Ramos et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Targeting Hepatitis B Virus-Infected Cells with a T-Cell Receptor-Like Antibody
Konduru S. R. Sastry et al.
JOURNAL OF VIROLOGY (2011)
Human Monoclonal Antibody Fragments Binding to Insulin-like Growth Factors I and II with Picomolar Affinity
Qi Zhao et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Natural killer cell engineering for cellular therapy of cancer
D. R. Shook et al.
TISSUE ANTIGENS (2011)
Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid Tumors
Duck Cho et al.
CLINICAL CANCER RESEARCH (2010)
WT1 (Wilms' Tumor Gene 1): Biology and Cancer Immunotherapy
Haruo Sugiyama
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
TCR Mimic Monoclonal Antibody Targets a Specific Peptide/HLA Class I Complex and Significantly Impedes Tumor Growth In Vivo Using Breast Cancer Models
Bhavna Verma et al.
JOURNAL OF IMMUNOLOGY (2010)
Structures of native and affinity-enhanced WT1 epitopes bound to HLA-A*0201 Implications for WT1-based cancer therapeutics
Oleg Y. Borbulevych et al.
MOLECULAR IMMUNOLOGY (2010)
Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation
Richard J. O'Reilly et al.
SEMINARS IN IMMUNOLOGY (2010)
A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS
Ulrich Keilholz et al.
BLOOD (2009)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
Rational development of high-affinity T-cell receptor-like antibodies
Guillaume Stewart-Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
One-step expression and purification of single-chain variable antibody fragment using an improved hexahistidine tag phagemid vector
Qi Zhao et al.
PROTEIN EXPRESSION AND PURIFICATION (2009)
Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies
Malka Epel et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
How a T Cell Receptor-like Antibody Recognizes Major Histocompatibility Complex-bound Peptide
Tatiana Mareeva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas
Anna Kruschinski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A T cell receptor associated with naturally occurring human tumor immunity
Bianca D. Santomasso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Recombinant antibodies with T-cell receptor-like specificity: Novel tools to study MHC class I presentation
Galit Denkberg et al.
AUTOIMMUNITY REVIEWS (2006)
T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: Identification, quantification, and characterization
K Rezvani et al.
CLINICAL CANCER RESEARCH (2005)
T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy
R Noy et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2005)
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
C Imai et al.
LEUKEMIA (2004)
Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity
V Mailander et al.
LEUKEMIA (2004)
Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivo
A Lev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions
CJ Cohen et al.
JOURNAL OF MOLECULAR RECOGNITION (2003)
X-ray snapshots of the maturation of an antibody response to a protein antigen
YL Li et al.
NATURE STRUCTURAL BIOLOGY (2003)
TCRs with high affinity for foreign pMHC show self-reactivity
PD Holler et al.
NATURE IMMUNOLOGY (2003)
A phage display selected Fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes
RA Willemsen et al.
GENE THERAPY (2001)
Antibody arrays for high-throughput screening of antibody-antigen interactions
RMT de Wildt et al.
NATURE BIOTECHNOLOGY (2000)
Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library
P Chames et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
